Replies to post #168146 on Biotech Values

[DewDiligence]

HZNP acquires (private) Crealta Holdings for $510M in cash:

http://finance.yahoo.com/news/horizon-pharma-plc-acquire-crealta-120000386.html

Creata is the reincarnation of Savient Pharmaceuticals, which filed for bankruptcy in 2013 (#msg-92997648), Creata’s main asset is Krystexxa, an approved drug for gout.